+ All Categories
Home > Documents > AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate...

AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate...

Date post: 04-Aug-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
14
AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5 th Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Foti, Mumbai - 40000 I The Manager- Listing National Stock Exchange oflndia Limited Exchange plaza, 5 th Floor, Plot No. Cl I, G Block Bandra -Kurla Complex, Bandra (E), Mumbai - 400051 Dear Sirs, 81lnglng stlmnca to pall1nla sine• 1979 Sub: Voting Results of 40 th Annual General Meeting of the Company held on August 7, 2019 - Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Clause 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we rnish below the details regarding voting results of 40 th Annual General Meeting of the Company held on Wednesday, August 7, 2019 at 3.00 pm at 'The Grand Ballroom' Conrad Bengaluru, Kensington Road, Ulsoor, Bengaluru- 560008: Date of AGM August 7, 2019 Total No of Share Holders as on Record Date 14,156 (cut-off date-31.07.2019) No. of shareholders present in the meeting either in person or through proxy: Promoters and Promoter Group 1 Public 455 No. of Shareholders attended the meeting through Video Conferencing: Promoters and Promoter Group NA Public Below is the resolution-wise combined result of remote e-voting and ballot: CORPORATE & REGO. OFFICE AstraZeneca Pharma India Ltd. P. B. No . 4525, Block N1. 12th Floor, Manyata Embassy Business Park. Rac henahalli, Outer Ring Road, Bangalore· 560 045, INDIA TEL : +91 80 6774 8000 F : +91 80 6774 8857 CIN : L24231KA1979PLC003563 WEB : www.astrazeneca.com/india FACTORY 12th Mile on Bellary Road Venkatala, Kattigenahalli Village Yelahanka Bangalore · 560 063 INDIA TEL : +91 80 6774 9000 FAX : +91 80 2846 2208 +91 80 6774 9628
Transcript
Page 1: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

AstraZeneca

August 9, 2019

The Manager- Listing BSE Limited

Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Foti,

Mumbai - 40000 I

The Manager- Listing National Stock Exchange oflndia Limited

Exchange plaza, 5th Floor, Plot No. Cl I, G Block Bandra -Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sirs,

81lnglng stlmnca to pall1nla sine• 1979

Sub: Voting Results of 40th Annual General Meeting of the Company held on

August 7, 2019 - Regulation 44 of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015

Pursuant to Clause 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish below the details regarding voting results of 40th Annual General Meeting of the Company held on Wednesday, August 7, 2019 at 3.00 pm at 'The Grand Ballroom' Conrad Bengaluru, Kensington Road, Ulsoor, Bengaluru- 560008:

Date of AGM August 7, 2019

Total No of Share Holders as on Record Date 14,156 ( cut-off date-31.07.2019)

No. of shareholders present in the meeting either in person or through proxy:

• Promoters and Promoter Group 1

• Public 455

No. of Shareholders attended the meeting through Video Conferencing:

• Promoters and Promoter GroupNA

• Public

Below is the resolution-wise combined result of remote e-voting and ballot:

CORPORATE & REGO. OFFICE

AstraZeneca Pharma India Ltd.

P. B. No . 4525, Block N1. 12th Floor, Manyata Embassy Business Park. Rachenahalli, Outer Ring Road, Bangalore· 560 045, INDIA

TEL : +91 80 6774 8000

FAX : +91 80 6774 8857

CIN : L24231KA1979PLC003563

WEB : www.astrazeneca.com/india

FACTORY

12th Mile on Bellary Road Venkatala, Kattigenahalli Village Yelahanka Bangalore · 560 063 INDIA

TEL : +91 80 6774 9000

FAX : +91 80 2846 2208

+91 80 6774 9628

Page 2: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Resolution( I)

Resolution required: (Ordinoiy / Special) Orclina,y

Whether promoter/promoter group are interested in 1hc:: No agcnda/rcsol ution?

Description of resolution considt!rt!d Adu pl ion of i\ccoun1s for the year ended March 31, 2019 and the Repo11s of 1hc Audi101Js and Directors thereon

Mode of No. of No. or % or Voles polled No. of voles

No. of % of votes in % of Votes Ca1ego1y

voting shares held votes polled 011 outstanding - i11 favour

vo1es- favour on against on

shares against votes polled votes polled

(I) (2) (3}=[(2)/(1)]•100 (4) (5) (6)=[(4)/(2)] ( 7);[(5)/(2)1 •100 •100

E-Vo1i11g 18750000 100 18750000 0 100 0

Promoter and Poll 18750000 0 0 0 0 0 0

Promoter Postal Ballot Group (if applicable)

0 0 0 0 0 0

Total 18750000 18750000 100 18750000 0 100 0

E-Voting 1034412 63.3223 1034412 0 100 0

Poll 1633567 0 0 0 0 0 0

Public-Institutions Postal Ballot 0 0

(if applicable) 0 0 0 0

Total 1633567 103,1412 63.3223 1034412 0 100 0

E-Vo1ing 2705 0.0586 2705 0 100 0

Poll 4616433 63922 1.3847 63922 0 100 0

Public- Non Institutions Postal Ballot 0 0

(if applicable) 0 0 0 0

Total ,1616433 66627 1.4433 66627 0 JOO 0

Total 25000000 19851039 79.4042 19851039 0 100 0

Whether resolution is Pass or Not. Yes

Disclosure of notes on resolution

Page 3: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Rcsolution(2)

Rcsolu1io11 required: (Ordinary/ Special) Ordina,y

\Vhdhcr pro111otcr/pro111ot<.:r group arc interested in the No

agenda/resolution?

Description of resolution considered Appointment of Mr. Gagandci.!p Singh Bedi, Managing Director (DIN:07844333) who re1ires hy ro1a1ion, and being cligiulc, oilers himself for rcappoi111111cnl

Mode of No. of No. of % of Voles polled

No. of votes No. of % of votes in % of Votes

Category voting shares held votes polled

on outstanding - in favour

voles - favour on against on shares agains1 votes polled vo1cs polled

(I) (2) (3)=[(2Y( I)]• JOO (4) (5) (6)=[(4Y(2)J (7)=[(5)/(2)1

•100 • 100

E-Voling 18750000 100 18750000 0 100 0

Promoter aud Poll

18750000 0 0 0 0 0 0

Promoter Postal Oallo1 Group (ifapplicauh!)

0 0 0 0 0 0

To1al 18750000 18750000 100 18750000 0 100 0

E-Vo1ing 1034412 63.3223 1034412 0 100 0

Poll 1633567

0 0 0 0 0 0 Public-Institutions Postal Ballol

0 0 0 0 0 0 (if applicauk)

Total 1633567 1034412 63.3223 1034412 0 100 0

E-Voling 2705 0.0586 2705 0 100 0

Poll 4616433

63915 1.3845 63915 0 100 0 Public- Non lnslitulions Postal Ballot

0 0 (if applicable)

0 0 0 0

Total 4616433 66620 1.443 I 66620 0 100 0

Tolal 25000000 19851032 79.4041 19851032 0 100 0

Whether resolulion is Pass or Nol. Yes

Disclosure of notes on resolution

Page 4: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Rcsolution(3)

Resolution required· (Ordina,y / Special) Ordina,y

Whether promotcr/pro111oter group an; i111crcs1cd in the No agc11da/rl.!sol11tio11?

Dcsc1 iplion of n::sol11tion considl.!red Appointment of'Ms. Weiying Sarah Wang (DIN: 08369289) as Non-Executive Dircc1or

Mode or No. of' No. or % of Votes polled

No. of votes No. or % ofvotc.:s in % of Votes Cntcgory

voling sharl.!s hdd voles on outstanding

- in favour votes- favour on against on

polled shares against votes po I led votes polled

(I) (2) (3)=[(2Y( I)]• 100 (4) (5) (6)=[(4Y(2)1 (7)=((5Y(2)J

•100 •100

E-Voting 18750000 100 18750000 0 100 0

Promoter and Poll 18750000

0 0 0 0 0 0

Promoter Postal Ballot Group (if applicable)

0 0 0 0 0 0

Total 18750000 18750000 100 18750000 0 100 0

E-Voting 1034•112 63.3223 1033114 1298 99.87•15 0.1255

Poll 1633567 0 0 0 0 0 0 Public-Institutions Postal Ballol 0 0 0 0 0 0

(if applicable)

Total 1633567 1034412 63.3223 1033114 1298 99.8745 0.1255

E-Voting 2705 0,0586 1100 1605 40.6654 59.3346

Poll 4616433 63922 1.3847 61085 2837 95.5618 4.4382

Public- Non Institutions Postal Ballot 0 0 0 0 0 0

(if applicable)

Total 4616433 66627 1.4433 62185 4442 93.333 6.667

Total 25000000 19851039 79.4042 19845299 5740 99.9711 0,0289

Whether resolution is Pass or Not. Yes

Disclosure of notes on resolution

Page 5: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Rcsolution(4)

Resolu1ion required: (Ordinary/ Special) Special

Whether promoter/promoh.:r group arc i111ercstcd in lhe No agenda/rl.!sol ution?

/\ppoinlmenl of Mr. Narayan K Seshadri (DIN: 00053563) as an Independent Description of resolution considered Direclor for a 1cm, of 5 consecu1ive years w.e.f., Seplember 30, 2019 to

September 29, 2024

Mo<k of No. of No. of % of Votes polled

No. of votes No. of %of votes in % of Voles Category

voting shares held votes 011 outstanding

- in favour VOIC$- favour on againsl on

polled shnrcs against votes polled votes polled

(I) (2) (3)=1(2)/( I)]' I 00 (4) (5) (6)=[(4)/(2)1 (7)=((5)/(2)1

•ioo • 100

E-Vo1ing 18750000 100 18750000 0 100 0

Prontolcr and Poll 18750000 0 0 0 0 0 0

Promolcr Posial Ballot Grou1, (ifapplieabk)

0 0 0 0 0 0

Tolal 18750000 18750000 100 18750000 0 100 0

E-Voting 1034412 63.3223 1027735 6677 99.3545 0.6455

Poll 1633567 0 0 0 0 0 0

Public-lnslitutions Postal Oallol 0 0

(ifapµlicabk) 0 0 0 0

Total 1633567 1034412 63.3223 1027735 6677 99.3545 0.6455

E-Vo1ing 2705 0.0586 2100 605 77.634 22.366

Poll 4616,133 63920 1.3846 63920 0 100 0

Public- Non Inslitutions Postal Ballot 0 0

(if applicabk) 0 0 0 0

To1al 4616433 66625 1.4432 66020 605 99.0919 0.9081

Tola! 25000000 19851037 79.4041 19843755 7282 99.9633 0,0367

Whether resolu1ion is Pass or Not. Yes

Disclosure of notes on resolution

Page 6: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Rcsolu1ion required: (Ordinary/ Special)

Whether µromotcr/promo1cr group are i111cn:::s1cd in the agcnda/resol ution'!

Description of resolution considered

Mode or No. of No. of Ca1egory voting shares held VOl<!S

polled

(I) (2)

E-Vo1ing 18750000

Pro11101cr and Poll 18750000 0 Promoter Postal 13allol Group (if applicable)

0

Tola! 18750000 18750000

E-Voting 1034412

Poll 1633567 0 Public-Institutions Postal Ballot 0

(if applicable)

Tolal 1633567 1034412

E-Voling 2655

Poll 4616433 63915 Public- Non Institutions Poslal Ballol 0 (if applicable)

Toial 4616433 66570

Total 25000000 19850982

Rcsolulion(S)

Ordina,y

No

Ra1ifica1io11 of Cosl Audito1Js rc111u11t!ralio11

% or Voles polled No. of vou::s

No. or on outstanding - in favour VOICS-

shares against

(3)=[(2)/( I)]• 100 (4) (5)

100 18750000 0

0 0 0

0 0 0

100 18750000 0

63.3223 1034412 0

0 0 0

0 0 0

63.3223 1034412 0

0.0575 2655 0

1.3845 61078 2837

0 0 0

1.442 63733 2837

79.4039 19848145 2837

Whelher resolution is Pass or Not.

Disclosure of notes on resolution

% ofvot<!s in favour on

voles polled

(6)=[(4)/(2)] • 100

100

0

0

100

100

0

()

100

100

95.5613

0

95.7383

99.9857

Yes

% of Voles against 011

voles polled

(7)=((5)/(2)] • 100

0

0

0

0

0

0

0

0

0

4.4387

0

4.2617

0.0143

�"arn,<i' � /,,

f Ba� alorc Q)

J � "'ls

lt ..

' ,,

Page 7: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Rcsol11tio11(6)

Resolution required: (Ordinary/ Special) Ordinary

Whc1hcr pro11101cr/promotcr group nrc interested in the Yes agcnda/n:solu1io11'?

Description ofrl.!solu1ion considered Approval of Material Related Pa11y Transactions l!ntcrcd into by the Company with AstraZeneca UK Limited during the financial year 2018-19

Mode or No. of No of % of Votes polled

No. ofvo1es No. of % ofvoh;s in % of Votes

Category voting shares hdd

votes on outstanding - in favour

voles- favour on against 011 polled shares against votes pol kd votes polled

(I) (2) (J)=f(2Y( I)]* I 00 (•I) (5) (6)=f(4Y{2)J (7)=[(5)/(2)] • 100 •100

E-Voting 0 0 0 0 0 0

Promoter and Poll 18750000 0 0 0 0 0 0

Promoter Postal Ballot Group (if applicable)

0 0 0 0 0 0

Total 18750000 0 0 0 0 0 0

E-Voting 1034412 63.3223 1034412 0 100 0

Poll 1633567 0 0 0 0 0 0

Public-Institutions Postal Bal lot 0 0

(if applicable) 0 0 0 0

Total 1633567 1034412 63.3223 1034412 0 100 0

E-Voting 2705 0.0586 1960 745 72.4584 27.5416

Poll 4616433 63920 1.3846 60083 3837 93.9972 6.0028

Public- Non Institutions Postal Ballot 0 0

(if applicable) 0 0 0 0

Total 4616433 66625 1.4432 62043 4582 93.1227 6.8773

Total 25000000 1101037 4.4041 1096455 4582 99.5838 0.4162

Whether resolution is Pass or Not. Yes

Disclosure of notes on resolution

Page 8: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Resolution(?)

Rcsolu1ion required: (Ordina,y / Special) Ordinary

Whc:ther pro111otcr/promotcr group arc interested in the Yes

agenda/resol 111ion'I

Approval of Material Related Pany Trnnsaclions 10 be entered into by the Dcsc, iplion or resolution considered Company wilh AstraZeneca UK Limited during 3 financial years (being April

I, 201910 March 31, 2022)

Mode of No. of No. of % of Votes polled

No. of votes No. of % of votes in % of Votes

Category voling shares held

votes 011 outstanding - in favour

votes - frtvour on against on polled shares against votes polled votes polled

(I) (2) (3)'=[(2)/( I )I* I 00 (4) (5) (6)=[(4)/(2)1 (7)=[(5)/(2)]

•100 •100

E-Voting 0 0 0 0 0 0

Promoter and Poll 18750000

0 0 0 0 0 0

Pro11101cr Postal Ballol Group (if applicable)

0 0 0 0 0 0

Tolal 18750000 0 0 0 0 0 0

E-Voting 1034412 63.3223 1034412 0 100 0

Poll 1633567

0 0 0 0 0 0 Public-Institutions Postal Ballol 0 0

(if applicable) 0 0 0 0

Tolal 1633567 1034412 63.3223 1034412 0 100 0

E-Voting 2705 0.0586 960 1745 35.4898 64.5102

Poll 4616433

63915 1.3845 60078 3837 93.9967 6.0033 Public- Non Institutions Postal Ballol

0 0 (if applicable) 0 0 0 0

Tolal 4616433 66620 1.4431 61038 5582 91.6211 8.3789

Total 25000000 1101032 4.4041 1095450 5582 99.493 0.507

Whelher resolulion is Pass or Not. Yes

Disclosure of 11otes on resolution

Page 9: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

VIJAYAKRISHNA KT BBM, LLB, FCS, ACMA

Company ecretary

SCRUTINIZER'S REPORT

# 496/4, II Floor, 10th Cross

Near Bashyam Circle, Sadashivanagar,

Bangal9re - 560 080, INDIA

Tel : +91 80 23610847, 41231106

e-mail : [email protected]

ktvijaykrishna@g ma i I. com

[Pursuant to Sections 108 & 109 of the Companies Act, 2013 and the Companies (Management & Administration) Rules, 2014]

To Mr. Narayan K Seshadri Chairman AstraZeneca Pharma India Limited Block N 1, 1 ih Floor, Manyata Embassy Business Park Rachenahalli, Outer Ring Road Bengaluru- 560 045

Dear Sir

I, Vijayakrishna KT, Company Secretary in Whole-Time Practice (FCS No. 1788, CP No. 980), having office at # 496/4, 2nd Floor, 10th Cross, Near Bashyam Circle,Sadashivanagar, Bengaluru - 560 080, duly appointed as Scrutinizer by AstraZeneca Pharma India Limited for the purpose of scrutinizing the voting through remote e-voting and through Polling Paper at the 40th Annual General· Meeting held on ?th ·August, 2019 at The Grand Ballroom. Conrad Bengaluru, Kensington Road, Ulsoor, Bengaluru - 560 008 pursuant to Sections 108 and 109 of the Companies Act, 2013 (the Act), read with Rules 20 and 21 of the Companies (Management & Administration) Rules, 2014 (the Rules) as amended from time to time and the provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), hereby furnish my Report to you.

The Management of the Company is responsible to ensure compliance of the requirements of the Companies Act, 2013 and Rules made there under relating to voting through remote e-voting and through Polling Papers at the Annual General Meeting venue for the resolutions proposed ln the Notice of 40th Annual General Meeting. My responsibility as a Scrutinizer is to. ensure that the voting process is conducted in a fair and transparent manner and is restricted to make a Scrutinizer's Report for the votes casts in "favour" or uagainst" the resolutions proposed in the Notice convening the 40th Annual ·General Meeting of the Company, based on the report provided by National Securities Depository Limited (NSDL), the agency engaged by the Co� ih t0.c ovide remote e-voting facility for voting through electronic means.

� ·'.'.!,_ .

f F -17P9 <!,J . . .

;. I :-7 1

Res : No. 66, Sathyanarayana layout, West o Chord Road, III Stage, Bangalore - 560 079, INDIA

Tel : +91 80 23221564

Page 10: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

In terms of the aforesaid Notice and as per the provisions of Section 108 of the Act, read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended, the e-voting was kept open for four days from 3rd August, 2019 (9.00 A.M. 1ST) till 6th August, 2019 (5.00 P.M. 1ST) and Members were requested to cast their votes electronically conveying their assent or dissent in respect of the resolutions on the e-voting platform.

The Members holding Equity Shares as on the '"cut-off date" i.e., 31st July, 2019 were entitled to vote on the Resolutions proposed in ·the Notice calling the 40th Annual General Meeting.

The Ballot Register was prepared to record Equity Shareholders' Asse.nt or Dissent received mentioning the particulars of name, address, folio number or client id of the Shareholders. number of shares held by them, nominal value of such shares, whether the shares have differential voting rights, if any, details of Polling Paper which are invalid.

The Polling Papers received were scrutinized and reconciled with the records maintained by the Company's Registrar and Share Transfer Agent (RTA). The Polling Papers which were incomplete, unsigned and wrongly signed have been rejected and treated as invalid.

At the end of the voting period on 6th August, 2019 (5.00 P. M. 1ST). the voting portal of NSDL was blocked forthwith.

The votes cast were unblocked on ?1h August, 2019, in presence of Ms. Sahana Bhat

and Ms. Ramya Hegde, who acted as witnesses as prescribed under su�-rule 3(xii) of Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended.

Thereafter. the details containing inter alia, the list of the members, who voted "for" or "against" each of the resolution that were put to vote, were derived from the Polling Papers as received and the report generated from the e-voting portal of NSDL i.e. www.evoting.nsdl.com and based on such reports

a. 45 (folio wise) members have cast their votes through remote e-:voting.b. 40 (folio wise) members have cast their votes through Polling Paper at the

Annual General Meeting.

The brief analysis of the results of the remote e-votir,g and Polling Papers are as under:

2

Page 11: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

ORDINARY BUSINESS:

Item No.1: Adoption of Financial Statements for the year ended March 31, 2019 and the Reports of the Board of Directors and Auditors thereon:

Ordinary Resolution:

I Particulars No. of votes contained in Percentage

Remote E-voting Polling Paper Total on Valid

votes

No o1 No. of No o1 No. of No 0 No. of members Votes· cast members Votes members Votes cast voted (shares) rvoted cast voted (shares)

(shares) Assent 45 19787117 29 63922 74 . ·19851039 100.00

Dissent 0 0 0 0 0 0 0

Total 45 19787117 29 63922 74 19851039 100.00

Abstained 0 0 11 1144 11 1144 NA / Invalid

Item No. 2: Appointment of Mr. Gagandeep Singh Bedi (DIN: 07844333) who retires by rotation, and being eligible, offers himself for re-appointment:

Ordinary Resolution:

Particulars No. of votes contained in Percentage

Remote E-voting Polling Paper Total on Valid

votes

No o◄ No. of No o1 No. of No 0 No. of members Votes cast members Votes members Votes cast voted (shares) voted cast �oted (shares)

(shares) Assent 45 19787117 26 63915 71 1.9851032 100·.oo

Dissent 0 0 0 0 0 0 0 Total 45 19787117 26 63915 71 19851032 100.00

Abstained 0 0 14 1159 14 1159 NA

/Invalid

�,�, � m_q I�] '�l �

3

Page 12: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

SPECIAL BUSINESS:

Item No. 3: Appointment of Ms. Weiying Sarah Wang (DIN: 08369289) as Non­Executive Director: Ordinary Resolution:

Particulars No. of votes contained in Percentage Remote E-voting Polling Paper Total on Valid votes No oi No. of No 01 No. of No 01 No. of members Votes cast members Votes members Votes cast voted (shares) r,.,oted cast voted (shares)

(shares) Assent 40 19784214 28 61085 68 19845299 99.97

Dissent 5 2903 1 2837 6 5740 0.03

Total 45 19787117 29 63922 74 19851039 100.00

Abstained 0 0 11 1144 11 1144 NA

/ Invalid

Item No. 4: Re-appointment of Mr. Narayan K Seshadri (DIN: .00053563) as an Independent Director for a second term of 5 years i.e., from September 30, 2019 to September 29, 2024:

Special Resolution:

j Particulars No: of votes contained in Percentage Remote E-voting Polling Paper Total on Valid

votes No 0 No. of No 0 No. of No 0 No. of members Votes cast' members Votes members Votes cast voted (shares) �oted cast �oted (shares)

(shares)

Assent 40 19779835 28 63920 68 19843755 99.96

Dissent 5 7282 0 0 5 7282 0,04 Total 45 19787117 28 63920 73 19851037 100.00

Abstained 0 0 12 1146 12 1146 NA

/ Invalid

. 5: Ratification of Cost Auditor's remuneration:

4

Page 13: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Ordinary Resolution:

Particulars No. of votes contained in Percentag

Remote E-voting Polli g Paper Total e on Valid

votes

No 01 No. of No o1 No. of No 0 No. of

members Votes cast members Votes members Votes cast

voted (shares) voted cast 1v1oted (shares)

(shares)

Assent 44 19787067 25 61078 69 19848145 99.99

Dissent 0 0 1 2837 1 2837 0.01

Total 44 19787067 26 63915 70 1985'0982 100.00

Abstained 0 0 14 1159 14 .1159 NA

/ Invalid

Item No. 6: Approval of Material Related Party Transactions entered into by the

Company with AstraZeneca UK Limited during the financial year 2018-19*"':

Ordinary Resolution:

Particulars No. of votes ·contained in Percentag

Remote E-voting Polling Paper Total e on Valid

votes

No o1 No. of No of No. of No o1 No. of

members Votes cast members Votes members Votes cast

voted (shares) voted cast voted (shares)

(shares)

Assent 40 1036372 26 60083 66 1096455 99.58

Dissent 4 745 2 3837 6 4582 0.42

Total 44 1037117 28 63920 72 1101037 100.00

Abstained 1 18750000 12 1146 13 18751146 NA

/ Invalid

Page 14: AstraZeneca · 2019-08-09 · AstraZeneca August 9, 2019 The Manager- Listing BSE Limited Corporate Relationship Dept., 5th Floor, New Trading Ring Rotunda Building, J Towers, Dalal

Ordinary Resolution:

Particulars No. of votes contained in Percentag

Remote E-voting Polling Paper Total e on Valid

votes

No o' No. of No 0 No. of No 0 No. of members Votes cast members Votes members Votes cast voted (shares) !Voted cast ivoted (shares)

(shares) Assent 39 1035372 24 60078 63 1095450 99.49

Dissent 5 1745 2 · 3837 7 5582 0.51 Total 44 1037117 26 63915 70 1101032 100.00

Abstained 1 18750000 14 1159 14 18751159 / Invalid

**Pursuant to Regulation 23(4) of the Listing Regulations, no Related Party shall vote to approve the resolutions in relation to the Material Related Party Transactions whether the entity is a Related Party to the particular transaction or not. Accordingly, in respect of the Resolutions Nos. 6 and 7, the votes cast by AstraZeneca Pharmaceuticals AB, being a 'Related Party' have been ignored.

Based on the foregoing, the Resolution Nos. from 1 to 7 in respect ·of Notice of 40th

Annual General Meeting may be deemed to have been passed by requisite majority.

All the relevant records relating to remote e�voting and Polling Papers are under my safe

custody and will be handed over to. the Chairman or �ompany Secretary for preserving

safely.

Date: 08.08.2019 Place: Bangalore

Witnesses: �J.<.V Sahana Bhat Ramya Hegde

6

NA


Recommended